Cancer Stem Cells and Pediatric Solid Tumors

Por Friedman, Gregory K., Gillespie, G. Yancey
Publicado em 2011

Combination strategies enhance oncolytic virotherapy

Por Friedman, Gregory K., Markert, James M., Gillespie, George Yancey
Publicado no Oncotarget (2017)

Response to radiation in renal medullary carcinoma

Por Walsh, Alexandra M., Fiveash, John B., Reddy, Alyssa T., Friedman, Gregory K.
Publicado em 2011

Oncolytic viral therapy: targeting cancer stem cells

Por Smith, Tyrel T, Roth, Justin C, Friedman, Gregory K, Gillespie, G Yancey
Publicado em 2014

Oncolytic virotherapy for pediatric malignancies: future prospects

Por Waters, Alicia M, Friedman, Gregory K, Ring, Eric K, Beierle, Elizabeth A
Publicado no Oncolytic Virother (2016)

Checkpoint Proteins in Pediatric Brain and Extracranial Solid Tumors: Opportunities for Immunotherapy

Por Ring, Eric K., Markert, James M., Gillespie, G. Yancey, Friedman, Gregory K.
Publicado no Clin Cancer Res (2016)

Oncolytic Virotherapy for the Treatment of Malignant Glioma

Por Foreman, Paul M., Friedman, Gregory K., Cassady, Kevin A., Markert, James M.
Publicado no Neurotherapeutics (2017)

PDCT-23. PROLIFERATION INDEX INFLUENCES INITIAL RESPONSE PATTERN OF PEDIATRIC HIGH-GRADE GLIOMAS TREATED WITH HSV-1 G207 ONCOLYTIC VIROTHERAPY

Por Bag, Asim, Li, Rong, Gillespie, Yancey, Markert, James, Johnston, James, Friedman, Gregory K
Publicado no Neuro Oncol (2017)

Herpes Simplex Virus Oncolytic Therapy for Pediatric Malignancies

Por Friedman, Gregory K, Pressey, Joseph G, Reddy, Alyssa T, Markert, James M, Gillespie, G Yancey
Publicado em 2009

Protocol for Reducing Time to Antibiotics in Pediatric Patients Presenting to an Emergency Department with Fever and Neutropenia: Efficacy and Barriers

Por Cohen, Clay, King, Amber, Lin, Chee Paul, Friedman, Gregory K., Monroe, Kathy, Kutny, Matthew
Publicado no Pediatr Emerg Care (2016)

Publication Outcomes of Abstracts from the American Society of Hematology Annual Meeting

Por Baddam, Sujatha, Cutter, Gary R., Wolfson, Julie A., Friedman, Gregory K., Lebensburger, Jeffrey D.
Publicado no Am J Hematol (2017)

Targeting Pediatric Cancer Stem Cells with Oncolytic Virotherapy

Por Friedman, Gregory K., Cassady, Kevin A., Beierle, Elizabeth A., Markert, James M., Gillespie, G. Yancey
Publicado em 2012

Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy

Por Friedman, Gregory K., Raborn, Joel, Kelly, Virginia M., Cassady, Kevin A., Markert, James M., Gillespie, G. Yancey
Publicado em 2013

Hypoxia Moderates γ(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures

Por Friedman, Gregory K, Haas, Marilyn C, Kelly, Virginia M, Markert, James M, Gillespie, George Yancey, Cassady, Kevin A
Publicado em 2012

CD133 Marks a Myogenically Primitive Subpopulation in Rhabdomyosarcoma Cell Lines that are Relatively Chemoresistant but Sensitive to Mutant HSV

Por Pressey, Joseph G., Haas, Marilyn C., Pressey, Christine S., Kelly, Virginia M., Parker, Jacqueline N., Gillespie, G. Yancey, Friedman, Gregory K.
Publicado em 2012

Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111

Por Friedman, Gregory K., Langford, Catherine P., Coleman, Jennifer M., Cassady, Kevin A., Parker, Jacqueline N., Markert, James M., Gillespie, G. Yancey
Publicado no J Neurooncol (2009)

Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain...

Por Waters, Alicia M., Johnston, James M., Reddy, Alyssa T., Fiveash, John, Madan-Swain, Avi, Kachurak, Kara, Bag, Asim K., Gillespie, G. Yancey, Markert, James M., Friedman, Gregory K.
Publicado no Hum Gene Ther Clin Dev (2017)

Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses

Por Friedman, Gregory K., Moore, Blake P., Nan, Li, Kelly, Virginia M., Etminan, Tina, Langford, Catherine P., Xu, Hui, Han, Xiaosi, Markert, James M., Beierle, Elizabeth A., Gillespie, G. Yancey
Publicado no Neuro Oncol (2016)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma()

Por Waters, Alicia M., Stafman, Laura L., Garner, Evan F., Mruthyunjayappa, Smitha, Stewart, Jerry E., Friedman, Gregory K., Coleman, Jennifer M., Markert, James M., Gillespie, G. Yancey, Beierle, Elizabeth A.
Publicado no Transl Oncol (2016)

Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002

Por Ring, Eric K., Li, Rong, Moore, Blake P., Nan, Li, Kelly, Virginia M., Han, Xiaosi, Beierle, Elizabeth A., Markert, James M., Leavenworth, Jianmei W., Gillespie, G. Yancey, Friedman, Gregory K.
Publicado no Mol Ther Oncolytics (2017)